TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21323911

Group type: EXPERIMENTAL
Intervention: Cockroach immunotherapy (IT) with Periplaneta americana extract
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 18268187

Group type: COMPARATOR
Intervention: Low-dose apomorphine hydrochloride (12.5 microg/kg/h and 25 microg/kg/h every 2 hours)
Number of subjects: 14

Group type: COMPARATOR
Intervention: High-dose apomorphine hydrochloride (50 microg/kg/h and 100 microg/kg/h every 2 hours)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 17062800

Group type: EXPERIMENTAL
Intervention: 12-month weight loss program including diet, exercise, and orlistat
Number of subjects: 48

Group type: COMPARATOR
Intervention: No intervention (controls)
Number of subjects: 48
Study: 14510908

Group type: EXPERIMENTAL
Intervention: DHEA (50 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 10945420

Group type: EXPERIMENTAL
Intervention: Motor Relearning Programme (MRP)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Bobath
Number of subjects: 61
Study: 8826606

Group type: EXPERIMENTAL
Intervention: Antibiotics plus G‐CSF (5 micrograms/kg/day, s.c.)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Antibiotics alone (ceftazidime, 2 g, i.v., every 8 h + amikacin 7.5 mg/kg, i.v., every 12 h)
Number of subjects: 119
Study: 1421390

Group type: EXPERIMENTAL
Intervention: rhuGM‐CSF 250 micrograms/m2 daily by continuous infusion after ABMT
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: rhuGM‐CSF
Number of subjects: 81
Study: 6721959

Group type: EXPERIMENTAL
Intervention: Ketamine anaesthesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thiopentone and halothane anaesthesia (Control)
Number of subjects: 0
Study: 29767227

Group type: EXPERIMENTAL
Intervention: 12-month exercise programme (3 times a week for 30 min)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 100
Study: 26799145

Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg three times a day
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (valacyclovir and acetaminophen only)
Number of subjects: 120
Study: 25719344

Group type: EXPERIMENTAL
Intervention: Ginger (3 g powdered ginger daily for 3 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (lactose, daily for 3 months)
Number of subjects: 0
Study: 23229846

Group type: EXPERIMENTAL
Intervention: Coach-led group intervention
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Self-directed DVD intervention
Number of subjects: 241

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 241
Study: 20869358

Group type: EXPERIMENTAL
Intervention: Plasma myeloperoxidase (MPO) levels measured prior to myocardial perfusion scintigraphy (MPS)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: MPO levels
Number of subjects: 267
Study: 18439766

Group type: EXPERIMENTAL
Intervention: Postoperative radiation therapy (PORT) in the observation arm
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Postoperative radiation therapy (PORT) in the chemotherapy arm
Number of subjects: 840

Group type: COMPARATOR
Intervention: Observation without PORT
Number of subjects: 840
Study: 17030751

Group type: EXPERIMENTAL
Intervention: Motor Activity Log (MAL) treatment group
Number of subjects: 222

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 222
Study: 15895715

Group type: EXPERIMENTAL
Intervention: rhASB 1.0 mg/kg/week
Number of subjects: 7

Group type: COMPARATOR
Intervention: rhASB 0.2 mg/kg/week
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: rhASB (both doses)
Number of subjects: 7
Study: 11683484

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 9392980

Group type: EXPERIMENTAL
Intervention: 120 mg intramuscular triamcinolone acetonide
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 360 mg intramuscular triamcinolone acetonide
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (previous year data)
Number of subjects: 22
Study: 7699233

Group type: EXPERIMENTAL
Intervention: Lactitol 0.3 g/kg bw per day
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Lactitol 0.5 g/kg bw per day
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 28
Study: 2439861

Group type: EXPERIMENTAL
Intervention: Two cycles of chemotherapy followed by radiotherapy
Number of subjects: 75

Group type: COMPARATOR
Intervention: Three cycles of chemotherapy alone
Number of subjects: 75
Study: 30479286

Group type: EXPERIMENTAL
Intervention: Half-dose MBI (150 MBq Tc-99m sestamibi; images acquired for 10 minutes per view)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Half-time MBI (300 MBq Tc-99m sestamibi; images acquired for 5 minutes per view)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Half-dose or half-time MBI
Number of subjects: 60
Study: 28538071

Group type: EXPERIMENTAL
Intervention: Manual bone scraper
Number of subjects: 25

Group type: COMPARATOR
Intervention: Ultrasonic insert
Number of subjects: 25
Study: 25808637

Group type: EXPERIMENTAL
Intervention: Albumin therapy
Number of subjects: 830

Group type: EXPERIMENTAL
Intervention: Endovascular therapy
Number of subjects: 830

Group type: EXPERIMENTAL
Intervention: Intravenous tissue plasminogen activator
Number of subjects: 830

Group type: COMPARATOR
Intervention: Control (Saline)
Number of subjects: 830

Group type: COMPARATOR
Intervention: Overall cohort
Number of subjects: 830

Group type: EXPERIMENTAL
Intervention: Symptomatic intracranial hemorrhage
Number of subjects: 830
Study: 24136301

Group type: EXPERIMENTAL
Intervention: Loteprednol etabonate (LE) gel 0.5%
Number of subjects: 813

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 813
Study: 21633719

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/salmeterol combination (FSC) 100/50 mcg BID
Number of subjects: 231

Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) 100 mcg BID
Number of subjects: 231
Study: 18978615

Group type: EXPERIMENTAL
Intervention: Ab-Slide
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Abdominal crunch
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Supine double leg thrust
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Side bridge
Number of subjects: 22
Study: 16526203

Group type: EXPERIMENTAL
Intervention: 200 mg of micronized fenofibrate
Number of subjects: 9795

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9795
Study: 12967068

Group type: EXPERIMENTAL
Intervention: Prototype powered toothbrush (new Crest SpinBrush, rippled bristle pattern)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control powered toothbrush (original Crest SpinBrush, flat bristle profile)
Number of subjects: 20
Study: 10355326

Group type: EXPERIMENTAL
Intervention: Structural violence affecting blacks
Number of subjects: 1384

Group type: COMPARATOR
Intervention: Interpersonal and institutional violence
Number of subjects: 1384

Group type: COMPARATOR
Intervention: Criminal violence
Number of subjects: 1384

Group type: COMPARATOR
Intervention: Trust in crime-control institutions
Number of subjects: 1384

Group type: COMPARATOR
Intervention: Authoritarian attitudes and norms
Number of subjects: 1384
Study: 7709266

Group type: EXPERIMENTAL
Intervention: Physical therapy
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Spinal manipulation
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Epidural steroid injections
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Traction
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Corsets
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Bed rest
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Narcotic analgesics
Number of subjects: 1200
Study: 1790087

Group type: EXPERIMENTAL
Intervention: Zinc acexamate (ZAC) 300 mg at single nocturnal dose
Number of subjects: 146

Group type: COMPARATOR
Intervention: Magaldrate (MAG) 800 mg bid
Number of subjects: 146

Group type: COMPARATOR
Intervention: Aceglutamide aluminium salt (AAL) 700 mg bid
Number of subjects: 146
Study: 6166245

Group type: EXPERIMENTAL
Intervention: Human leukocyte interferon (5 to 7 days therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30095762

Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 110
Study: 28899366

Group type: EXPERIMENTAL
Intervention: Physical activity calorie expenditure (PACE) food labels
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no PACE labeling)
Number of subjects: 0
Study: 25784587

Group type: EXPERIMENTAL
Intervention: High-intensity locomotor training (70%-80% of heart rate reserve)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low-intensity locomotor training (30%-40% of heart rate reserve)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-intensity training first
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low-intensity training first
Number of subjects: 12
Study: 23619543

Group type: EXPERIMENTAL
Intervention: Therapeutic Kinesio taping (KT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham Kinesio taping (KT)
Number of subjects: 38
Study: 20579524

Group type: EXPERIMENTAL
Intervention: Fortified milk (0.5 L/d) containing eicosapentaenoic acid, docosahexaenoic acid, oleic acid, vitamins A, B(6), E, and folic acid
Number of subjects: 72

Group type: COMPARATOR
Intervention: Semiskimmed milk (0.5 L/d)
Number of subjects: 72
Study: 19378582

Group type: EXPERIMENTAL
Intervention: Intravenous clonidine (2.5 microg.kg(‐1))
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16478764

Group type: EXPERIMENTAL
Intervention: Letrozole (2.5 mg) with metformin
Number of subjects: 59

Group type: COMPARATOR
Intervention: Clomiphene (100 mg) with metformin
Number of subjects: 59
Study: 14556881

Group type: EXPERIMENTAL
Intervention: Damped sine wave monophasic transthoracic cardioversion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Truncated exponential biphasic transthoracic cardioversion
Number of subjects: 0
Study: 10821990

Group type: EXPERIMENTAL
Intervention: Behavioral day treatment plus abstinence contingent housing and work therapy (DT+)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Behavioral day treatment alone (DT)
Number of subjects: 110
Study: 9032870

Group type: EXPERIMENTAL
Intervention: Radiosurgery
Number of subjects: 25
Study: 1816597

Group type: EXPERIMENTAL
Intervention: 20-min exercise at 100 Watts (high exercise)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 20-min exercise at 25 Watts (low exercise)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 20-min no exercise (control)
Number of subjects: 30
Study: 6339921

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 0
Study: 3889759

Group type: COMPARATOR
Intervention: 5-FU alone (15 mg/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination treatment with cyclophosphamide (20 mg/kg) and 5-FU (15 mg/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Weight loss greater than 10%
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: No weight loss
Number of subjects: 30
Study: 30188171

Group type: EXPERIMENTAL
Intervention: Behavioral Parent Training (BPT)
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 343

Group type: COMPARATOR
Intervention: Information-Only Control (IOC)
Number of subjects: 343
Study: 26762678

Group type: EXPERIMENTAL
Intervention: Mnemonic arm
Number of subjects: 27

Group type: COMPARATOR
Intervention: Rote memorization arm
Number of subjects: 27
Study: 24880449

Group type: EXPERIMENTAL
Intervention: Amoxicillin and clavulanate (875/125mg)
Number of subjects: 546

Group type: COMPARATOR
Intervention: Amoxicillin (1g)
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 546
Study: 23055587

Group type: EXPERIMENTAL
Intervention: Tempered chlorhexidine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Non-tempered chlorhexidine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sterile water
Number of subjects: 30
Study: 20430912

Group type: EXPERIMENTAL
Intervention: Osteopathy in the cranial field (single intervention)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Light pressure applied to the cranium (control group)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Osteopathy in the cranial field (treatment group)
Number of subjects: 29
Study: 18468447

Group type: EXPERIMENTAL
Intervention: Robicsek technique
Number of subjects: 86

Group type: COMPARATOR
Intervention: Conventional sternal closure
Number of subjects: 86
Study: 15811060

Group type: EXPERIMENTAL
Intervention: Full-mouth scaling and root planing (SRP)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Oral hygiene instruction and professional tooth cleaning
Number of subjects: 42
Study: 12055113

Group type: EXPERIMENTAL
Intervention: Walking group W1 (55% VO(2)MAX, 1500 kcal/week)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Walking group W2 (45% VO(2)MAX, 1500 kcal/week)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Walking group W3 (55% VO(2)MAX, 1000 kcal/week)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Walking group W4 (45% VO(2)MAX, 1000 kcal/week)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: All exercise groups
Number of subjects: 121
Study: 10604501

Group type: EXPERIMENTAL
Intervention: Home-based programme of strength and balance retraining exercises
Number of subjects: 213

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 213
Study: 8819807

Group type: EXPERIMENTAL
Intervention: Holter monitoring (HM) for 24 hours during common everyday activities and after suspending anti-ischemic therapy
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Patients with anamnestic evidence of myocardial infarction
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Holter monitoring in patients with stable angina, especially if elderly
Number of subjects: 99
Study: 1758528

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rhEPO) administered intravenously
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rhEPO) administered subcutaneously
Number of subjects: 0

Group type: COMPARATOR
Intervention: Recombinant human erythropoietin (rhEPO) with albumin as preservative
Number of subjects: 0

Group type: COMPARATOR
Intervention: Recombinant human erythropoietin (rhEPO) without albumin as preservative
Number of subjects: 0
Study: 7202832

Group type: EXPERIMENTAL
Intervention: Mictral (3-day course)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ampicillin (7-day course)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mictral and Ampicillin (both groups)
Number of subjects: 0
Study: 31298632

Group type: EXPERIMENTAL
Intervention: Implicit e‐cigarette use anywhere message
Number of subjects: 2201

Group type: COMPARATOR
Intervention: Explicit e‐cigarette use anywhere message
Number of subjects: 2201
Study: 29726480

Group type: EXPERIMENTAL
Intervention: Nicorandil (2 mg injected into the coronary artery)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (200 μg injected into the coronary artery)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (PCI and balloon pre-dilation only)
Number of subjects: 120
Study: 25434645

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHD) spray on umbilical cord three times a day for three days after cord fall
Number of subjects: 140

Group type: COMPARATOR
Intervention: Routine umbilical cord care (control group)
Number of subjects: 140
Study: 24266715

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4-8 mg
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 22116543

Group type: EXPERIMENTAL
Intervention: Mephenamic acid microspheres (250 mg)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Ponstan® capsule (250 mg)
Number of subjects: 4
Study: 20670466

Group type: EXPERIMENTAL
Intervention: Low-fat diet (LF; 20-30% of energy)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: High-MUFA diet (MUFA; 35-45% of energy; >20% of fat as MUFA)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control diet (35% of energy as fat)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: All diets
Number of subjects: 106
Study: 17695946

Group type: EXPERIMENTAL
Intervention: Music
Number of subjects: 207

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 207
Study: 15805229

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Insulin-glucose infusion (euglycemic insulin clamp; high insulin, suppressed FFA)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Somatostatin-heparin infusion (suppressed insulin, high FFA)
Number of subjects: 8
Study: 10792200

Group type: EXPERIMENTAL
Intervention: 4 mg cilansetron
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 8 mg cilansetron
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9310023

Group type: EXPERIMENTAL
Intervention: Inhaled salmeterol (50 micrograms b.i.d. via diskhaler)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Identical placebo
Number of subjects: 16
Study: 7506172

Group type: EXPERIMENTAL
Intervention: nimesulide 1.5 mg/kg/day 3 times daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: paracetamol 120 to 288mg (5 to 12ml) 3 times daily for 3 to 7 days
Number of subjects: 40
Study: 2882289

Group type: EXPERIMENTAL
Intervention: Rhesus rotavirus vaccine (MMU‐18006) - 10^4 plaque-forming units, orally administered
Number of subjects: 247

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247
Study: 31268481

Group type: EXPERIMENTAL
Intervention: Panitumumab plus fluorouracil-leucovorin (arm A)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Panitumumab (arm B)
Number of subjects: 229
Study: 28078540

Group type: EXPERIMENTAL
Intervention: Capecitabine 2500 mg/m2/day for 12 months (16 cycles)
Number of subjects: 1304

Group type: COMPARATOR
Intervention: Capecitabine 2500 mg/m2/day for 6 months (8 cycles)
Number of subjects: 1304
Study: 25143556

Group type: EXPERIMENTAL
Intervention: Paricalcitol (PCT) 1 μg/day for 6 months
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Withdrawal of Paricalcitol (PCT) after 6 months
Number of subjects: 15
Study: 23223106

Group type: EXPERIMENTAL
Intervention: Transport group
Number of subjects: 52

Group type: COMPARATOR
Intervention: Stationary group
Number of subjects: 52
Study: 21660675

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine for calming Gan and suppressing hyperactive yang (CGSHY)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 64
Study: 19186717

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Chinese herbal decoction (Culuanpao decoction, Cupailuan decoction, Cuhuangti decoction)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Oral administration of Clomiphene and intramuscular injection of Chorionic Gonadotropin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with medication
Number of subjects: 50
Study: 17107268

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Open-label, uncontrolled trials
Number of subjects: 0
Study: 14751651

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 76
Study: 11216934

Group type: EXPERIMENTAL
Intervention: Thicker condom
Number of subjects: 283

Group type: COMPARATOR
Intervention: Standard condom
Number of subjects: 283
Study: 8344096

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice daily
Number of subjects: 1052

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg at bedtime
Number of subjects: 1052

Group type: EXPERIMENTAL
Intervention: Ranitidine treatment (combined data)
Number of subjects: 1052

Group type: COMPARATOR
Intervention: N/A (indicators of slow-healing)
Number of subjects: 1052

Group type: EXPERIMENTAL
Intervention: Antiplatelet drugs (in DU patients)
Number of subjects: 1052
Study: 3575022

Group type: EXPERIMENTAL
Intervention: Elimination of suspected foods, open challenges, and double‐blind food challenges
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Reintroduction of foods into the diet at 1- to 3-month intervals
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Rechallenge at regular intervals
Number of subjects: 480
Study: 30077298

Group type: EXPERIMENTAL
Intervention: Fentanyl iontophoretic transdermal system (ITS)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Structured training for fentanyl ITS
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo fentanyl ITS
Number of subjects: 91
Study: 26926639

Group type: EXPERIMENTAL
Intervention: LJP538
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LJP539
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CSJ148 (combination of LJP538 and LJP539)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25450470

Group type: EXPERIMENTAL
Intervention: Nanocrystal dispersion 650 mg/5.2 mL (test 1)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Nanocrystal dispersion 675 mg/5.4 mL (test 2)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional formulation 800 mg/20 mL (reference)
Number of subjects: 38
Study: 23339978

Group type: EXPERIMENTAL
Intervention: Docetaxel 70 mg/m2 administered intravenously on day 1 of a 3-week cycle.
Number of subjects: 50
Study: 21955649

Group type: EXPERIMENTAL
Intervention: Fruit and vegetable intake
Number of subjects: 2533

Group type: EXPERIMENTAL
Intervention: Fruit intake
Number of subjects: 2533

Group type: EXPERIMENTAL
Intervention: Vitamin C-rich fruit and vegetable intake
Number of subjects: 2533

Group type: EXPERIMENTAL
Intervention: Vitamin C intake
Number of subjects: 2533

Group type: EXPERIMENTAL
Intervention: Vitamin E intake
Number of subjects: 2533

Group type: EXPERIMENTAL
Intervention: Vegetable intake
Number of subjects: 2533

Group type: EXPERIMENTAL
Intervention: Beta-carotene-rich fruit and vegetable intake
Number of subjects: 2533